{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:20:53Z","timestamp":1784100053736,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271794"],"award-info":[{"award-number":["82271794"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Project of Huashan Hospital, Fudan University.","award":["KY2024-664"],"award-info":[{"award-number":["KY2024-664"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01930-x","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T08:07:39Z","timestamp":1759219659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Novel Compound Heterozygous Mutation in the IL12RB1 Gene Causes Susceptibility To Mycobacterium Tilburgii Infection"],"prefix":"10.1007","volume":"45","author":[{"given":"Mengqing","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peidong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingluan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"1930_CR1","doi-asserted-by":"crossref","unstructured":"Ogishi M, Yang R, Rodriguez R, Golec DP, Martin E, Philippot Q, Bohlen J, Pelham SJ, Arias AA, Khan T et al. Inherited human ITK deficiency impairs IFN-\u03b3 immunity and underlies tuberculosis. J Exp Med 2023, 220(1).","DOI":"10.1084\/jem.20220484"},{"issue":"4 Pt 1","key":"1930_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1542\/peds.98.4.774","volume":"98","author":"JL Casanova","year":"1996","unstructured":"Casanova JL, Blanche S, Emile JF, Jouanguy E, Lamhamedi S, Altare F, St\u00e9phan JL, Bernaudin F, Bordigoni P, Turck D, et al. Idiopathic disseminated Bacillus Calmette-Gu\u00e9rin infection: a French National retrospective study. Pediatrics. 1996;98(4 Pt 1):774\u20138.","journal-title":"Pediatrics"},{"key":"1930_CR3","doi-asserted-by":"publisher","unstructured":"Bousfiha AA, Jeddane L, Moundir A, Poli MC, Aksentijevich I, Cunningham-Rundles C, et al. The 2024 update of IUIS phenotypic classification of human inborn errors of immunity. Journal of Human Immunity. 2025. https:\/\/doi.org\/10.70962\/jhi.20250002.","DOI":"10.70962\/jhi.20250002"},{"issue":"2","key":"1930_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1006\/clim.1999.4688","volume":"91","author":"DM Frucht","year":"1999","unstructured":"Frucht DM, Sandberg DI, Brown MR, Gerstberger SM, Holland SM. IL-12-independent costimulation pathways for interferon-gamma production in familial disseminated Mycobacterium avium complex infection. Clin Immunol. 1999;91(2):234\u201341.","journal-title":"Clin Immunol"},{"issue":"5528","key":"1930_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1126\/science.1061154","volume":"293","author":"S Dupuis","year":"2001","unstructured":"Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, Harris J, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science. 2001;293(5528):300\u20133.","journal-title":"Science"},{"issue":"5","key":"1930_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jaci.2024.01.021","volume":"153","author":"A Khavandegar","year":"2024","unstructured":"Khavandegar A, Mahdaviani SA, Zaki-Dizaji M, Khalili-Moghaddam F, Ansari S, Alijani S, et al. Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): a systematic review. J Allergy Clin Immunol. 2024;153(5):1432\u201344.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1930_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cell.2023.11.036","volume":"187","author":"AL Neehus","year":"2024","unstructured":"Neehus AL, Carey B, Landekic M, Panikulam P, Deutsch G, Ogishi M, Arango-Franco CA, Philippot Q, Modaresi M, Mohammadzadeh I, et al. Human inherited CCR2 deficiency underlies progressive polycystic lung disease. Cell. 2024;187(2):390\u2013e408323.","journal-title":"Cell"},{"issue":"6","key":"1930_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin Immunol. 2014;26(6):454\u201370.","journal-title":"Semin Immunol"},{"key":"1930_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1034\/j.1600-065X.2000.17810.x","volume":"178","author":"S Dupuis","year":"2000","unstructured":"Dupuis S, D\u00f6ffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev. 2000;178:129\u201337.","journal-title":"Immunol Rev"},{"key":"1930_CR10","doi-asserted-by":"crossref","unstructured":"Le Voyer T, Neehus AL, Yang R, Ogishi M, Rosain J, Alroqi F, Alshalan M, Blumental S, Al Ali F, Khan T et al. Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease. Proc Natl Acad Sci U S A 2021, 118(15).","DOI":"10.1073\/pnas.2102804118"},{"issue":"3","key":"1930_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jaci.2024.12.1078","volume":"155","author":"S Boisson-Dupuis","year":"2025","unstructured":"Boisson-Dupuis S, Bastard P, B\u00e9ziat V, Bustamante J, Cobat A, Jouanguy E, et al. The monogenic landscape of human infectious diseases. J Allergy Clin Immunol. 2025;155(3):768\u201383.","journal-title":"J Allergy Clin Immunol"},{"issue":"6693","key":"1930_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl2016","volume":"384","author":"J-L Casanova","year":"2024","unstructured":"Casanova J-L, MacMicking JD, Nathan CF. Interferon-\u03b3 and infectious diseases: lessons and prospects. Science. 2024;384(6693):eadl2016.","journal-title":"Science"},{"issue":"1","key":"1930_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10875-025-01885-z","volume":"45","author":"L Zhao","year":"2025","unstructured":"Zhao L, Ma J, Sun Y, Yu X, Lu Y, Qian H, et al. Deepening understanding of the clinical features and diagnostic approaches to anti-Interferon-Gamma autoantibody associated adult-onset immunodeficiency in the last 20 years: a case report and literature review. J Clin Immunol. 2025;45(1):93.","journal-title":"J Clin Immunol"},{"issue":"17","key":"1930_CR14","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1016\/j.cell.2022.07.004","volume":"185","author":"JL Casanova","year":"2022","unstructured":"Casanova JL, Abel L. From rare disorders of immunity to common determinants of infection: following the mechanistic thread. Cell. 2022;185(17):3086\u2013103.","journal-title":"Cell"},{"issue":"6","key":"1930_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","volume":"89","author":"L de Beaucoudrey","year":"2010","unstructured":"de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12R\u03b21 deficiency: a survey of 141 patients from 30 countries. Medicine. 2010;89(6):381\u2013402.","journal-title":"Medicine"},{"issue":"1","key":"1930_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-022-00358-x","volume":"24","author":"A Errami","year":"2023","unstructured":"Errami A, El Baghdadi J, Ailal F, Benhsaien I, Ouazahrou K, Abel L, et al. Mendelian susceptibility to mycobacterial disease: an overview. Egypt J Med Hum Genet. 2023;24(1):7.","journal-title":"Egypt J Med Hum Genet"},{"issue":"4","key":"1930_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/cid\/ciae302","volume":"79","author":"M Horne","year":"2024","unstructured":"Horne M, Woolley I, Lau JSY. The use of long-term antibiotics for suppression of bacterial infections. Clin Infect Dis. 2024;79(4):848\u201354.","journal-title":"Clin Infect Dis"},{"key":"1930_CR18","doi-asserted-by":"publisher","first-page":"691956","DOI":"10.1155\/2011\/691956","volume":"2011","author":"AA Alangari","year":"2011","unstructured":"Alangari AA, Al-Zamil F, Al-Mazrou A, Al-Muhsen S, Boisson-Dupuis S, Awadallah S, Kambal A, Casanova JL. Treatment of disseminated mycobacterial infection with high-dose IFN-\u03b3 in a patient with IL-12R\u03b21 deficiency. Clin Dev Immunol. 2011;2011:691956.","journal-title":"Clin Dev Immunol"},{"issue":"19","key":"1930_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1056\/NEJM199405123301904","volume":"330","author":"SM Holland","year":"1994","unstructured":"Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med. 1994;330(19):1348\u201355.","journal-title":"N Engl J Med"},{"issue":"3","key":"1930_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00431-004-1599-2","volume":"164","author":"T Ulrichs","year":"2005","unstructured":"Ulrichs T, Fieschi C, Nevicka E, Hahn H, Brezina M, Kaufmann SH, et al. Variable outcome of experimental interferon-gamma therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin-12Rbeta1-deficient Slovakian children. Eur J Pediatr. 2005;164(3):166\u201372.","journal-title":"Eur J Pediatr"},{"issue":"15","key":"1930_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35616","volume":"10","author":"M Yuan","year":"2024","unstructured":"Yuan M, Dong G, Han N, Yan L, Tang H. Disseminated Mycobacterium tilburgii infection in a person with AIDS: a case report. Heliyon. 2024;10(15):e35616.","journal-title":"Heliyon"},{"issue":"17","key":"1930_CR22","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1182\/blood-2012-08-448902","volume":"121","author":"N Schmitt","year":"2013","unstructured":"Schmitt N, Bustamante J, Bourdery L, Bentebibel SE, Boisson-Dupuis S, Hamlin F, et al. IL-12 receptor \u03b21 deficiency alters in vivo T follicular helper cell response in humans. Blood. 2013;121(17):3375\u201385.","journal-title":"Blood"},{"issue":"3","key":"1930_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3201\/eid1203.051139","volume":"12","author":"D Wagner","year":"2006","unstructured":"Wagner D, Vos M, Buiting AG, Serr A, Bergmans AM, Kern W, et al. Mycobacteriumtilburgii infections. Emerg Infect Dis. 2006;12(3):532\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"D1","key":"1930_CR24","doi-asserted-by":"publisher","first-page":"D690","DOI":"10.1093\/nar\/gkac920","volume":"51","author":"BP Alcock","year":"2023","unstructured":"Alcock BP, Huynh W, Chalil R, Smith KW, Raphenya AR, Wlodarski MA, Edalatmand A, Petkau A, Syed SA, Tsang KK, et al. CARD 2023: expanded curation, support for machine learning, and resistome prediction at the comprehensive antibiotic resistance database. Nucleic Acids Res. 2023;51(D1):D690\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1930_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-025-01480-2","volume":"17","author":"D Lu","year":"2025","unstructured":"Lu D, Kalantar KL, Glascock AL, Chu VT, Guerrero ES, Bernick N, et al. Simultaneous detection of pathogens and antimicrobial resistance genes with the open source, cloud-based, CZ ID platform. Genome Med. 2025;17(1):46.","journal-title":"Genome Med"},{"issue":"5","key":"1930_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jiac.2021.12.025","volume":"28","author":"K Shinohara","year":"2022","unstructured":"Shinohara K, Matsumura Y, Sakagami T, Morioka S, Yoshizawa K, Aoki K, et al. Cervical abscess caused by Mycobacterium tilburgii in a patient carrying anti-interferon gamma autoantibody: a case report and literature review. J Infect Chemother. 2022;28(5):699\u2013704.","journal-title":"J Infect Chemother"},{"key":"1930_CR27","doi-asserted-by":"crossref","unstructured":"Saad J, Drancourt M, Hannan MM, Stapleton PJ, Grandjean Lapierre S. Whole-Genome sequencing of Mycobacterium Tilburgii strain MEPHI. Microbiol Resour Announc 2019, 8(40).","DOI":"10.1128\/MRA.00933-19"},{"issue":"4","key":"1930_CR28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s15010-005-4118-0","volume":"33","author":"M Kolditz","year":"2005","unstructured":"Kolditz M, Halank M, Spornraft-Ragaller P, Schmidt H, H\u00f6ffken G. Localized pulmonary infection associated with Mycobacterium tilburgii in an HIV-infected patient. Infection. 2005;33(4):278\u201381.","journal-title":"Infection"},{"issue":"11","key":"1930_CR29","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/00002030-200007280-00028","volume":"14","author":"E Richter","year":"2000","unstructured":"Richter E, R\u00fcsch-Gerdes S, Niemann S, Stoehr A, Plettenberg A. Detection, identification, and treatment of a novel, non-cultivable Mycobacterium species in an HIV patient. AIDS. 2000;14(11):1667\u20138.","journal-title":"AIDS"},{"issue":"5","key":"1930_CR30","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1128\/JCM.02385-08","volume":"47","author":"TN Palmore","year":"2009","unstructured":"Palmore TN, Shea YR, Conville PS, Witebsky FG, Anderson VL, Rupp Hodge IP, et al. Mycobacterium tilburgii, a newly described, uncultivated opportunistic pathogen. J Clin Microbiol. 2009;47(5):1585\u20137.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"1930_CR31","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1128\/JCM.05460-11","volume":"49","author":"NG Hartwig","year":"2011","unstructured":"Hartwig NG, Warris A, van de Vosse E, van der Zanden AG, Sch\u00fclin-Casonato T, van Ingen J, et al. Mycobacterium tilburgii infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis. J Clin Microbiol. 2011;49(12):4409\u201311.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"1930_CR32","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s10875-013-9941-y","volume":"33","author":"K Schepers","year":"2013","unstructured":"Schepers K, Schanden\u00e9 L, Bustamante J, Van Vooren J-P, de Suremain M, Casanova J-L, et al. IL-12R\u03b21 deficiency and disseminated Mycobacterium tilburgii disease. J Clin Immunol. 2013;33(8):1285\u20138.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1930_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jiac.2015.02.006","volume":"21","author":"T Akpinar","year":"2015","unstructured":"Akpinar T, Bakkaloglu OK, Ince B, Tufan F, Kose M, Poda M, et al. Case report of fatal Mycobacterium tilburgii infection. J Infect Chemother. 2015;21(7):538\u201340.","journal-title":"J Infect Chemother"},{"key":"1930_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000000586","author":"T ten Doesschate","year":"2018","unstructured":"ten Doesschate T, Meinders A-J, Voorn GP, Kummer JA, Moeniralam H. Hyperammonemia as a manifestation of Mycobacterium tilburgii infection: a case report. Infect Dis Clin Pract. 2018. https:\/\/doi.org\/10.1097\/IPC.0000000000000586.","journal-title":"Infect Dis Clin Pract"},{"issue":"9","key":"1930_CR35","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3201\/eid2109.150461","volume":"21","author":"J Heyckendorf","year":"2015","unstructured":"Heyckendorf J, Aries SP, Greinert U, Richter E, Schultz H, Lange C. Functional immune reconstitution by Interleukin-2 adjunctive therapy for hiv\/mycobacterial co-infection. Emerg Infect Dis. 2015;21(9):1685\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"1930_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1084\/jem.20021769","volume":"197","author":"C Fieschi","year":"2003","unstructured":"Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, et al. Low penetrance, broad resistance, and favorable outcome of Interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med. 2003;197(4):527\u201335.","journal-title":"J Exp Med"},{"issue":"8","key":"1930_CR37","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1182\/blood-2013-01-474213","volume":"121","author":"A Puel","year":"2013","unstructured":"Puel A, Casanova JL. Autoantibodies against cytokines: back to human genetics. Blood. 2013;121(8):1246\u20137.","journal-title":"Blood"},{"issue":"8","key":"1930_CR38","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725\u201334.","journal-title":"N Engl J Med"},{"issue":"25","key":"1930_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003927","volume":"95","author":"CY Chi","year":"2016","unstructured":"Chi CY, Lin CH, Ho MW, Ding JY, Huang WC, Shih HP, et al. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections. Medicine (Baltimore). 2016;95(25):e3927.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"1930_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076371","volume":"8","author":"P Wongkulab","year":"2013","unstructured":"Wongkulab P, Wipasa J, Chaiwarith R, Supparatpinyo K. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand. PLoS ONE. 2013;8(9):e76371.","journal-title":"PLoS ONE"},{"issue":"8","key":"1930_CR41","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","volume":"121","author":"CY Chi","year":"2013","unstructured":"Chi CY, Chu CC, Liu JP, Lin CH, Ho MW, Lo WJ, et al. Anti-IFN-\u03b3 autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121(8):1357\u201366.","journal-title":"Blood"},{"key":"1930_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178263","author":"JN Peel","year":"2024","unstructured":"Peel JN, Yang R, Le Voyer T, Gervais A, Rosain J, Bastard P, et al. Neutralizing IFN-\u03b3 autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI178263.","journal-title":"J Clin Invest"},{"issue":"3","key":"1930_CR43","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","volume":"137","author":"CL Ku","year":"2016","unstructured":"Ku CL, Lin CH, Chang SW, Chu CC, Chan JF, Kong XF, Lee CH, Rosen EA, Ding JY, Lee WI, et al. Anti-IFN-\u03b3 autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia. J Allergy Clin Immunol. 2016;137(3):945-e948948.","journal-title":"J Allergy Clin Immunol"},{"key":"1930_CR44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211387","author":"A Puel","year":"2022","unstructured":"Puel A, Bastard P, Bustamante J, Casanova J-L. Human autoantibodies underlying infectious diseases. J Exp Med. 2022. https:\/\/doi.org\/10.1084\/jem.20211387.","journal-title":"J Exp Med"},{"issue":"7","key":"1930_CR45","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1007\/s10875-023-01537-0","volume":"43","author":"B Zhang","year":"2023","unstructured":"Zhang B, Fan J, Huang C, Fan H, Chen J, Huang X, et al. Characteristics and outcomes of anti-interferon gamma antibody-associated adult onset immunodeficiency. J Clin Immunol. 2023;43(7):1660\u201370.","journal-title":"J Clin Immunol"},{"key":"1930_CR46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1146\/annurev.immunol.26.021607.090344","volume":"26","author":"C King","year":"2008","unstructured":"King C, Tangye SG, Mackay CR. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol. 2008;26:741\u201366.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1930_CR47","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jaci.2015.05.036","volume":"136","author":"CS Ma","year":"2015","unstructured":"Ma CS, Wong N, Rao G, Avery DT, Torpy J, Hambridge T, Bustamante J, Okada S, Stoddard JL, Deenick EK, et al. Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies. J Allergy Clin Immunol. 2015;136(4):993\u2013e10061001.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1930_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1084\/jem.192.4.517","volume":"192","author":"CE Verhagen","year":"2000","unstructured":"Verhagen CE, de Boer T, Smits HH, Verreck FAW, Wierenga EA, Kurimoto M, Lammas DA, Kumararatne DS, Sanal O, Kroon FP, et al. Residual type 1 immunity in patients genetically deficient for Interleukin 12 receptor \u03b21 (IL-12R\u03b21): evidence for an IL-12R\u03b21\u2013Independent pathway of IL-12 responsiveness in human T cells. J Exp Med. 2000;192(4):517\u201328.","journal-title":"J Exp Med"},{"issue":"97","key":"1930_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf2047","volume":"9","author":"D Casta\u00f1o","year":"2024","unstructured":"Casta\u00f1o D, Wang S, Atencio-Garcia S, Shields EJ, Rico MC, Sharpe H, et al. Il-12 drives the differentiation of human T follicular regulatory cells. Sci Immunol. 2024;9(97):eadf2047.","journal-title":"Sci Immunol"},{"issue":"80","key":"1930_CR50","doi-asserted-by":"publisher","first-page":"eabq5204","DOI":"10.1126\/sciimmunol.abq5204","volume":"8","author":"Q Philippot","year":"2023","unstructured":"Philippot Q, Ogishi M, Bohlen J, Puchan J, Arias AA, Nguyen T, Martin-Fernandez M, Conil C, Rinchai D, Momenilandi M, et al. Human IL-23 is essential for IFN-\u03b3-dependent immunity to mycobacteria. Sci Immunol. 2023;8(80):eabq5204.","journal-title":"Sci Immunol"},{"issue":"5","key":"1930_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28187","volume":"67","author":"S Patel","year":"2020","unstructured":"Patel S, Uppuluri R, Vellaichamy Swaminathan V, Ravichandran N, Melarcode Ramanan K, Raj R. Mendelian susceptibility to mycobacterial disease-challenges in hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2020;67(5):e28187.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1930_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.24953\/turkjped.2016.04.002","volume":"58","author":"\u00c7 Tan","year":"2016","unstructured":"Tan \u00c7, \u00c7a\u011fda\u015f-Ayvaz D, Metin A, Keskin \u00d6, Tezcan \u0130, Sanal \u00d6. Clinical and genetic features of IL12Rb1 deficiency: single center experience of 18 patients. Turk J Pediatr. 2016;58(4):356\u201361.","journal-title":"Turk J Pediatr"},{"issue":"8","key":"1930_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s10875-024-01779-6","volume":"44","author":"VV Iyengar","year":"2024","unstructured":"Iyengar VV, Chougule A, Gowri V, Taur P, Bodhanwala M, Desai MM. Interferon alpha therapy in MSMD. J Clin Immunol. 2024;44(8):174.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1930_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-024-01661-5","volume":"44","author":"J Rosain","year":"2024","unstructured":"Rosain J, Kiykim A, Michev A, Kendir-Demirkol Y, Rinchai D, Peel JN, et al. Recombinant IFN-\u03b31b treatment in a patient with inherited IFN-\u03b3 deficiency. J Clin Immunol. 2024;44(3):62.","journal-title":"J Clin Immunol"},{"issue":"592","key":"1930_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg7673","volume":"13","author":"G Pollara","year":"2021","unstructured":"Pollara G, Turner CT, Rosenheim J, Chandran A, Bell LCK, Khan A, et al. Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease. Sci Transl Med. 2021;13(592):eabg7673.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1930_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2023","unstructured":"Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23(1):38\u201354.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1930_CR57","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.jinf.2005.07.009","volume":"52","author":"SD Rosenzweig","year":"2006","unstructured":"Rosenzweig SD, Yancoski J, Bernasconi A, Krasovec S, Marciano BE, Casimir L, et al. Thirteen years of culture-positive M. bovis-BCG infection in an IL-12Rbeta1 deficient patient: treatment and outcome. J Infect. 2006;52(3):e69-72.","journal-title":"J Infect"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01930-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:01:37Z","timestamp":1777309297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01930-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1930"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01930-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Written informed consent was obtained from the patient and her parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent To Participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent To Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"133"}}